Subsequently, it targets HIF-1α and facilitates its translocation to the nucleus, where it exerts its transcriptional functions and upregulates the expression of glycolytic enzymes and glucose transport proteins associated with HCC progression. Here, HIF1A is linked to hepatocellular carcinoma.